Dosidal · Switzerland

Rivaroxaban NOBEL, Filmtabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68009 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68009
atc: B01AF01
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2022-04-28
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: B01AF01
authorisation_number: 68009
form: FILM
holder: NOBEL Pharma Schweiz AG
holder_partner_nr: 1102452
it_number: 06.03.0.
name: Rivaroxaban NOBEL, Filmtabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
87AWsdizbjNVD9fpYRJrOcTN9wbNAqpuBp7gnyausWfTtwxezdb4AKczcVx0E5LgJuPWTuN-9cyEIQnQ04iSSg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:68009 · Related records in other markets · Dosidal